statistiche ricercatore

Nome	#
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression.	169
Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer	168
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells	161
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression	109
Nuclear receptors and pathogenesis of pancreatic cancer	109
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition	108
Peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model	106
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION	102
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS	87
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression	77
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION	76
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS	67
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY	63
Totale	1.402

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	14	0	0	0	0	0	0	0	0	0	0	8	6
2020/2021	89	6	8	7	11	5	7	3	7	7	13	10	5
2021/2022	82	7	3	6	5	3	5	0	5	4	3	11	30
2022/2023	239	19	52	16	18	11	41	30	13	27	1	9	2
2023/2024	114	2	14	10	3	9	24	4	32	3	1	8	4
2024/2025	605	29	64	49	110	184	66	12	42	19	13	17	0
Totale													1.402